Clinical Study Evaluating the Efficacy and Safety of CID v2.2 in Glaucoma Surgery
NCT: NCT05625958 · ACTIVE_NOT_RECRUITING
Publicidade
ID NCTNCT05625958
EstadoACTIVE_NOT_RECRUITING
Data de início2023-03-23
Conclusão2028-09-01
Resumo breve
The purpose of this study is to evaluate the safety and effectiveness of implanting a new version of an interposition supraciliary implant (SV22) as a stand-alone therapy for lowering intraocular pressure (IOP) in patients with primary open and narrow angle glaucoma who have failed at least one class of topical medical therapy
Fonte oficial
Ver no ClinicalTrials.gov →Dados provenientes da API do ClinicalTrials.gov. Para consultar o estado mais recente, veja o registo oficial.